Immuron Ltd current report, Q2 FY2017

Business Context and Reporting Period

Immuron Limited, a foreign private issuer, filed Form 6-K on June 23, 2017. The filing discloses the publication of an Appendix 3B (New Issue Announcement) on the Australian Securities Exchange regarding an application for the quotation of additional securities.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a corporate action rather than a financial performance statement.

Material Changes

The material change disclosed is the initiation of a new issue of securities. The company has submitted an application for the quotation of these additional securities on the Australian Securities Exchange.

Guidance, Outlook, and Risks

  • Forward-Looking Statements: The filing contains forward-looking statements subject to risks and uncertainties detailed in the company's Form F-1 and other SEC reports.
  • Offer Restrictions: The document explicitly states it is not an offer to sell securities in the United States. No securities may be offered or sold to U.S. persons absent registration or an applicable exemption.
  • Exhibit: The full details of the new issue are contained in Exhibit 99.1 (Appendix 3B).

Investor Verification Checklist

  • Review Exhibit 99.1 (Appendix 3B) for the specific terms, size, and pricing of the new securities issue.
  • Verify the company's current cash position and capital requirements in the most recent Form 20-F to understand the necessity of this capital raise.
  • Confirm the status of the securities quotation application on the Australian Securities Exchange.
  • Check for any subsequent filings regarding the completion or cancellation of the proposed issue.